Ginkgo Bioworks Holdings (DNA) Profit After Tax Growth (3y) (2023 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -4.58% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 25.73% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -26.30% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -12.42% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -34.12% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 30.84% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 35.35% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 6.62% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.84% |
| Mar 31, 2026 | 25.94% |
| Dec 31, 2025 | 21.64% |
| Sep 30, 2025 | 50.67% |
| Jun 30, 2025 | 55.20% |
| Mar 31, 2025 | 46.46% |
| Dec 31, 2024 | 59.14% |
| Sep 30, 2024 | 18.03% |
| Jun 30, 2024 | -58.62% |
| Mar 31, 2024 | -31.22% |
| Dec 31, 2023 | -65.79% |
| Sep 30, 2023 | -126.73% |